L-Arginine in Cancer Immunity and Therapy

Area of Science:

• Oncology
• Immunology
• Metabolic pathways

Background:

• L-Arginine (L-Arg) is a versatile amino acid with significant implications in cancer biology and therapy.
• L-Arg influences antitumor effects primarily through immune regulation.
• Its role is complex, acting as both an inhibitor of malignant cell growth and a modulator of therapeutic efficacy.

Purpose of the Study:

• To explore the multifaceted roles of L-Arginine in cancer biology and therapy.
• To investigate L-Arg's potential as an adjuvant and predictive biomarker in cancer treatment.
• To understand the impact of microbiota-mediated L-Arg metabolism on tumor progression and immune response.

Main Methods:

• Review of existing research on L-Arginine's mechanisms in cancer.
• Analysis of L-Arg's role in immune regulation and tumor growth inhibition.
• Investigation of microbiota-mediated L-Arg metabolic pathways and their influence on cancer.

Main Results:

• L-Arg demonstrates antitumor effects via immune regulation, inhibiting malignant cell growth.
• L-Arg shows potential as a predictive biomarker for immunotherapy response.
• Tumor-specific heterogeneity exists: L-Arg elimination is effective in auxotrophic tumors, while supplementation benefits non-auxotrophic cancers.

Conclusions:

• The clinical application of L-Arg is complex due to tumor-specific heterogeneity.
• Context-dependent and biomarker-guided strategies are crucial for L-Arg therapy.
• Integrating L-Arg modulation with other therapies offers novel approaches for cancer treatment.